Glenmark shares fall over 9% on USFDA warning letter
Shares of Glenmark Pharmaceuticals tumbled over 9 per cent on Monday after the company received a warning letter from the US health regulator for its Baddi facility in Himachal Pradesh.
On the BSE, shares of the drug firm closed 9.30 per cent lower at Rs 286.30. Intra-day, the stock nosedived 14.54 per cent to its 52-week low level of Rs 269.75
Disclaimer: No Business Standard Journalist was involved in creation of this content